in february 2006, rotateq was approved for inclusion in the recommended u.s. vaccination schedule, following its approval by the food and drug administration. premarketing studies found that rotateq was effective and safe, with an incidence of adverse events comparable to placebo. rotateq has been credited (by peter hotez) with saving hundreds of lives a day. offit received an unspecified sum of money for his interest in rotateq. offit was elected a fellow of the committee for skeptical inquiry, in 2015.